
Zeiss unveils UWF imaging
Bringing competition to the growing ultra-widefield (UWF) imaging space, Zeiss’ medical technology division has unveiled its Clarus 500 UWF fundus imaging technology.
4293 articles

Bringing competition to the growing ultra-widefield (UWF) imaging space, Zeiss’ medical technology division has unveiled its Clarus 500 UWF fundus imaging technology.

The Xen Gel Implant, a new innovation in glaucoma management for patients whose condition is not being well managed with drops, is now available in New Zealand.

Joevy Lim, an honours student in Auckland University’s ophthalmology department, and her team ‘Suture Future’ have won first prize in the 2017 Velocity 100k Challenge, winning a total of $25,000 to support the development of their new business venture.

Transitions Optical has launched a large suite of new point-of-sale (POS) materials available free to eyecare practices. The new suite includes window and wall posters, counter and reading cards, dispensing mats and consumer brochures.

Two-star Michelin chef Michel Roux Jnr has experienced two sight-threatening retinal detachments. “It’s hard to describe, but it just didn’t feel right,” he told media about the experience.

The 2018 RANZCO New Zealand Branch Annual Scientific Meeting, with the associated New Zealand ophthalmic nurses and orthoptics meetings, will be held at the Hilton hotel in downtown Auckland from the 11-12 May, 2018.

Ozurdex, a long-acting intravitreal steroid, delivered via a sustained-release ocular implant is now available and funded for New Zealand adult diabetic macular oedema (DMO) patients, which is welcome news, say Kiwi retina specialists.

Ophthalmology New Zealand (ONZ) has launched a new website as part of its transformation to a more commercial and thus professional umbrella body to better service New Zealand’s ophthalmologists.

J&J Vision (formerly AMO) has appointed Camille Furnandiz as a specialist sales representative for New Zealand, effectively doubling New Zealand’s on the ground surgical sales team.

A new study¹ by the Centre for Public Health at the Queen’s University in Belfast, Northern Ireland, has shown that multicolour imaging has a higher sensitivity for detecting early age-related macular degeneration (AMD) compared to colour fundus photography (CFP).

Following a bit of a backlash from some Kiwi ophthalmologists, aflibercept is back on the government’s Pharmaceutical Management Agency’s (Pharmac’s) funding agenda and has been recommended as the second line anti-VEGF treatment, replacing ranibizumab.

New Zealand medical retina specialist and well-known macular degeneration awareness champion, Dr Dianne Sharp, was awarded the RANZCO Distinguished Service Award at the 49th Congress for her services to ophthalmology and the community.